Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
World Journal of Urology|June 24, 2015
Intraoperative frozen section monitoring during nerve-sparing radical prostatectomy: evaluation of partial secondary resection of neurovascular bundles and its effect on oncologic and functional outcomeGeorgios Hatzichristodoulou, Stefan Wagenpfeil, Gregor Weirich, et al.Journal of Cancer Research and Clinical Oncology|January 30, 2013
Detection of circulating tumor cells in different stages of prostate cancerMark Thalgott, Brigitte Rack, Tobias Maurer, et al.The Journal of Urology|August 31, 2015
CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1Anuja Sathe, Nicole Koshy, Sebastian C Schmid, et al.BMC Cancer|June 9, 2015
Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patientsMark Thalgott, Brigitte Rack, Matthias Eiber, et al.European Urology|May 11, 2015
Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancerTobias Maurer, Gregor Weirich, Margret Schottelius, et al.Journal of Hematology & Oncology|March 7, 2014
Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancerMark Thalgott, Thomas Horn, Matthias M Heck, et al.Oncotarget|August 31, 2016
[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomySarah M Schwarzenböck, Anna Knieling, Michael Souvatzoglou, et al.Oncology|March 14, 2015
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09)Günter Niegisch, Margitta Retz, Mark Thalgott, et al.European Urology|August 19, 2017
AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and EnzalutamideAnna Katharina Seitz, Silvia Thoene, Andreas Bietenbeck, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2016
Prospective evaluation of [<sup>11</sup>C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancerSarah M Schwarzenböck, Matthias Eiber, Günther Kundt, et al.Pageof 3